Clinical trials: Continuous Venovenous Hemofiltration
Critically Ill, Acute Kidney Injury
Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose.
Rationale: A higher citrate dose during continuous venovenous hemofiltration provides better anticoagulation but possibly a higher risk of citrate accumulation in case of metabolic limitations.
- Trial name
- NCT02194569
- Testing
- Citrate
- Where
- Belgium
- Volunteers
- 36 people
- Sponsor
- Ziekenhuis Oost-Limburg
Poisoning by Paraquat With Undetermined Intent
Role of CVVH in Patients With Acute Paraquat Poisoning
Paraquat poisoning is characterized by multiple organ failure and pulmonary fibrosis with respiratory failure. Accumulating evidence suggested that continuous venovenous hemofiltration (CVVH) had a beneficial role in the…
- Trial name
- PQ (NCT01709604)
- Testing
- CVVH, Standardized therapy regimens
- Where
- 2 sites in China
- Volunteers
- 110 people
- Sponsor
- Ai Peng
Kidney Failure, Acute
Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration
Dialysis requires thinning of the blood to prevent clotting in the dialysis machine. Thinning of the blood is necessary but some forms of blood thinners may cause bleeding.
- Trial name
- NCT00583765
- Testing
- Regional citrate anticoagulation
- Where
- Canada
- Volunteers
- 20 people
- Sponsor
- University of Alberta